Chemomab Therapeutics Ltd. (CMMB) Balance Sheet
As of 2025-12-31 (20-F), Chemomab Therapeutics Ltd. (CMMB) reported total assets of $13.8M, total liabilities of $1.5M and shareholders' equity of $12.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $7.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CMMBChemomab Therapeutics Ltd.Follow CMMB — free
—
Price chart with a free account
- Market cap
- 7.5M
- P/E TTM
- 1.1
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 18 Nov, in 25 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Dec 25 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.5 | 7.6 | 12.3 | 11.7 | 15.2 | 13.5 | 9.3 | 6.1 | 7.6 | 7.6 | |
| Receivables | — | 3.4 | 0.4 | — | — | — | — | — | — | — | |
| Current assets | 1.9 | 10.9 | 18.2 | 11.8 | 62.7 | 41.7 | 20.9 | 16.0 | 13.4 | 13.4 | |
| Total assets | 2.1 | 12.8 | 19.8 | 12.5 | 64.4 | 43.1 | 22.2 | 17.0 | 13.8 | 13.8 | |
| Current liabilities | 2.7 | 2.7 | 4.1 | 1.3 | 2.7 | 6.7 | 4.8 | 3.2 | 1.5 | 1.5 | |
| Total liabilities | 2.7 | 3.0 | 4.8 | 1.7 | 2.9 | 6.8 | 5.2 | 3.4 | 1.5 | 1.5 | |
| Shareholders' equity | -0.6 | 9.8 | 12.4 | 10.8 | 61.5 | 36.2 | 17.0 | 13.5 | 12.3 | 12.3 |
USD millions · SEC XBRL
Chemomab Therapeutics Ltd. — questions
- How much cash does Chemomab Therapeutics Ltd. have?
- $7.6M in cash and cash equivalents as of 2025-12-31.
- What are Chemomab Therapeutics Ltd.'s total assets?
- $13.8M as of 2025-12-31.
- What is Chemomab Therapeutics Ltd.'s shareholders' equity?
- $12.3M as of 2025-12-31.
Every figure on this page comes from Chemomab Therapeutics Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.